18 completed, 4 terminated, 2 unknown, 1 withdrawn. 25 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 25 | Completed 18, Terminated 4, Unknown 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Ibandronic Acid: new trials by email Literature Review of Ibandronic Acid trials Research Report on Ibandronic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis ibandronate, Placebo - Aseptic Hip Necrosis, Hip Necrosis | Phase 3 | Terminated | Brigitte Jolles, MD | 8 | 2014-06-01 | 2017-05-17 |
| Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis Test group, Reference group - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | Alvogen Korea | 201 | 2011-12-01 | 2016-11-01 |
| A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 41 | 2011-04-01 | 2015-08-13 |
| A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates Ibandronate, Denosumab - Postmenopausal Osteoporosis | Phase 3 | Completed | Amgen | 833 | 2009-07-01 | 2013-02-11 |
| Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients Ibandronate, Vitamin Supplements - Hematological Malignancies | Phase 3 | Completed | M.D. Anderson Cancer Center | 78 | 2008-12-09 | 2018-09-13 |
| PTH & Ibandronate Combination Study (PICS) PTH(1-84), Ibandronate, Placebo injection - Osteoporosis | Phase 2 / Phase 3 | Completed | University of California, San Francisco | 44 | 2008-05-01 | 2013-11-05 |
| BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis. Placebo, ibandronate [Bonviva/Boniva] - Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 68 | 2007-06-01 | 2016-03-02 |
| Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis ibandronic acid 0.5mg, RIS placebo, 1.0mg ibandronic acid - Primary Osteoporosis | Phase 3 | Completed | Chugai Pharmaceutical | 1265 | 2007-03-01 | 2012-08-02 |
| The Effect Of Oral Ibandronate In Male Osteoporosis Ibandronate, placebo - Male Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 135 | 2007-01-01 | 2009-12-21 |
| Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. Placebo, Ibandronate - Renal Transplant | Phase 2 / Phase 3 | Unknown | Smerud Medical Research International AS | 130 | 2007-01-01 | 2010-03-24 |
| A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease Ibandronate - Pain; Bone Neoplasms; Neoplasm Metastasis | Phase 3 | Completed | Hoffmann-La Roche | 97 | 2006-12-01 | 2016-11-02 |
| BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. Ibandronate - Post-Menopausal Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 677 | 2006-12-01 | 2016-10-28 |
| S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone ibandronate, zoledronate, quality-of-life assessment - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Withdrawn | SWOG Cancer Research Network | 2006-05-01 | 2013-11-13 | |
| Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma Ibandronate, Zoledronate - Multiple Myeloma | Phase 3 | Terminated | Hoffmann-La Roche | 89 | 2006-02-01 | 2016-07-22 |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Unknown | Wales Cancer Trials Unit | 1404 | 2006-01-01 | 2013-03-13 |
| A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer Ibandronate - Pain; Bone Neoplasms; Neoplasm Metastasis | Phase 3 | Completed | Hoffmann-La Roche | 334 | 2006-01-01 | 2016-03-23 |
| A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain ibandronate [Bondronat], zoledronic acid - Pain, Bone Neoplasm | Phase 3 | Terminated | Hoffmann-La Roche | 96 | 2005-08-01 | 2017-08-16 |
| A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease ibandronate [Bondronat], zoledronic acid - Pain, Bone Neoplasm | Phase 3 | Terminated | Hoffmann-La Roche | 163 | 2005-07-01 | 2017-08-16 |
| S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. clodronate disodium, ibandronate sodium, zoledronic acid - Breast Cancer | Phase 3 | Completed | SWOG Cancer Research Network | 6097 | 2005-07-01 | 2021-07-02 |
| Study of Investigational Drug in Osteoporosis (MK-0217-908) Placebo, ibandronate - Postmenopausal Osteoporosis | Phase 3 | Completed | Organon and Co | 203 | 2004-12-01 | 2022-02-02 |
Showing 20 of 25. Sign in to see all of them.
Neoplasm Metastasis (7) · Osteoporosis, Postmenopausal (6) · Pain (6) · Osteoporosis (5) · Bone Neoplasms (4) · Breast Neoplasms (4) · Humoral Hypercalcemia Of Malignancy (2) · Bone Diseases, Metabolic (1) · Breast Neoplasms, Male (1) · Hematologic Neoplasms (1) · Multiple Myeloma (1) · Prostatic Neoplasms (1)
Hoffmann-La Roche (12) · SWOG Cancer Research Network (2) · Alvogen Korea (1) · Amgen (1) · Brigitte Jolles, MD (1) · Cancer Research UK (1) · Chugai Pharmaceutical (1) · GBG Forschungs GmbH (1) · M.D. Anderson Cancer Center (1) · Organon and Co (1) · Smerud Medical Research International AS (1) · University of California, San Francisco (1) · Wales Cancer Trials Unit (1)
United States (7) · France (6) · Germany (6) · United Kingdom (6) · Australia (4) · Hungary (4) · Italy (4) · Mexico (4) · Poland (4) · Switzerland (4) · Belgium (3) · Canada (3) · Norway (3) · Argentina (2) · Bosnia and Herzegovina (2)
Alexander H Paterson, MD, FRCP (1) · Carla I. Falkson, MD (1) · Dawn Hershman, MD (1) · Dennis M. Black, PhD (1) · Elizabeth C. Dees, MD (1) · Heather Purnell (1) · Huifang Lu, MD, PHD (1) · James N. Ingle, MD (1) · Julie R. Gralow, MD (1) · Katherine Monson (1) · Kathy S. Albain, MD (1) · Knut T Smerud, MSc (1)
PMID 21975558, PMID 22791766, PMID 23589163, PMID 23812464, PMID 24332514, PMID 28274254, PMID 31776637, PMID 32929540, PMID 34037241, PMID 37797387, PMID 38979716, PMID 39588131
2005 (1), U10CA037429 (1)